/images/ppid_59c68470-image-177010256285886601.webp)
What is the story about?
Indoco Remedies Ltd. reported a wider net loss for the December quarter. The company posted a net loss of ₹29.8 crore for the quarter, compared with a loss of ₹26.4 crore in the corresponding period last year.
Revenue rose 8.5% year-on-year to ₹445.4 crore from ₹410.6 crore. Operating performance strengthened, with EBITDA coming in at ₹31.5 crore, nearly tripling from ₹12 crore a year ago.
EBITDA margins expanded to 7.1% from 2.9% in the year-ago quarter.
Shares of Indoco Remedies were reacting positively to the improved operating metrics and were trading around 9.38% higher in trade today.
Revenue rose 8.5% year-on-year to ₹445.4 crore from ₹410.6 crore. Operating performance strengthened, with EBITDA coming in at ₹31.5 crore, nearly tripling from ₹12 crore a year ago.
EBITDA margins expanded to 7.1% from 2.9% in the year-ago quarter.
Shares of Indoco Remedies were reacting positively to the improved operating metrics and were trading around 9.38% higher in trade today.
/images/ppid_a911dc6a-image-177010122433114975.webp)
